AdaptHealth Corp. (NASDAQ:AHCO) Holdings Decreased by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. lowered its holdings in AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 7.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,138,380 shares of the company's stock after selling 91,984 shares during the period. Charles Schwab Investment Management Inc. owned 0.85% of AdaptHealth worth $10,837,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the business. Pacer Advisors Inc. purchased a new position in shares of AdaptHealth in the 4th quarter worth $76,271,000. Principal Financial Group Inc. raised its holdings in shares of AdaptHealth by 204.0% in the 4th quarter. Principal Financial Group Inc. now owns 1,652,765 shares of the company's stock worth $15,735,000 after purchasing an additional 1,109,021 shares during the period. State Street Corp lifted its stake in shares of AdaptHealth by 19.8% in the 3rd quarter. State Street Corp now owns 4,124,284 shares of the company's stock valued at $46,316,000 after purchasing an additional 681,816 shares in the last quarter. FMR LLC grew its holdings in shares of AdaptHealth by 9.3% during the 3rd quarter. FMR LLC now owns 7,350,549 shares of the company's stock worth $82,547,000 after purchasing an additional 624,645 shares during the period. Finally, Geode Capital Management LLC raised its holdings in AdaptHealth by 12.2% in the third quarter. Geode Capital Management LLC now owns 2,451,173 shares of the company's stock valued at $27,532,000 after buying an additional 265,712 shares during the period. 82.67% of the stock is currently owned by institutional investors and hedge funds.

AdaptHealth Stock Up 1.8 %

Shares of AHCO stock traded up $0.19 during mid-day trading on Wednesday, reaching $10.48. 1,198,461 shares of the company were exchanged, compared to its average volume of 1,162,071. The company has a market capitalization of $1.41 billion, a P/E ratio of -6.35, a P/E/G ratio of 1.08 and a beta of 1.30. The business's 50 day simple moving average is $10.01 and its 200 day simple moving average is $10.17. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. AdaptHealth Corp. has a fifty-two week low of $8.35 and a fifty-two week high of $11.90.

Analysts Set New Price Targets

AHCO has been the subject of several recent research reports. Royal Bank of Canada increased their price objective on shares of AdaptHealth from $11.00 to $14.00 and gave the stock an "outperform" rating in a research report on Wednesday, February 26th. Truist Financial raised their price objective on AdaptHealth from $12.00 to $14.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. Canaccord Genuity Group upped their target price on AdaptHealth from $13.00 to $14.00 and gave the stock a "buy" rating in a research report on Wednesday, February 26th. UBS Group reduced their price target on AdaptHealth from $12.00 to $11.00 and set a "buy" rating on the stock in a research report on Thursday, February 13th. Finally, Robert W. Baird increased their price objective on shares of AdaptHealth from $14.00 to $16.00 and gave the company an "outperform" rating in a research report on Thursday, February 27th. Five investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company currently has an average rating of "Buy" and a consensus target price of $13.80.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.